Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study

Acute graft versus host disease (aGVHD) remains a major problem after allogeneic hematopoietic stem cell transplantation. Standard frontline therapy for aGVHD involves corticosteroids. However, fewer than half of patients have a lasting complete response. The long-term mortality rate of steroid-refr...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Yamin Tan, Haowen Xiao, Depei Wu, Yi Luo, Jianping Lan, Qifa Liu, Kang Yu, Jimin Shi, Jingsong He, Weiyan Zheng, Xiaoyu Lai, Yuanyuan Zhu, Kaili Du, Yishan Ye, Yanmin Zhao, Gaofeng Zheng, Yongxian Hu, Xiaoyan Han, Yanlong Zheng, Guoqing Wei, Zhen Cai, He Huang
格式: Artigo
語言:Inglês
出版: Taylor & Francis Group 2017-03-01
叢編:OncoImmunology
主題:
basiliximab
etanercept
hematopoietic stem cell transplantation
steroid-refractory acute gvhd
在線閱讀:http://dx.doi.org/10.1080/2162402X.2016.1277307
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍